Sodium Alginate/ Magnesium Alginate
Indications
Registered South African indications:
- Gastric regurgitation
- Gastro-oesophageal reflux
Cautions
Contraindications
- Hypersensitivity to the active ingredients or any of the excipients in this combination product
- Known or suspected renal impairment as sodium content (approx. 21mg or 0.92mmol per dose) may add risk of hypernatraemia
- Intestinal obstruction
- Established diarrhoea
- Situations where excessive water loss is likely, e.g. fever diarrhoea, vomiting or high room temperature
- Gastroenteritis where the appropriate treatment is rehydration with fluid replacement
Caution
- Hepatic impairment
- Hypernatraemia
Adult dosage
Not indicated for use in adults
Paediatric dosage
Paed. forms avail. in SA and covered in this monograph: pdr
Gastric regurgitation
Gastro-oesophageal reflux
Reflux associated with hiatus hernia
Between 1-2 years
Sodium alginate/ Magnesium alginate
225/87.5 (mg/0.65g)
- <4.5kg: Oral (pdr): 1 dose, after each feed; Max: 6 doses/24hrs
- >4.5kg: Oral (pdr): 2 doses, after each feed; Max: 6 doses/24hrs
See additional prescribing points for dose preparation
Special populations
Pregnancy
- Not indicated for use in adults
Breastfeeding
Renal Impairment
Hepatic Impairment
Elderly
Porphyria Information
Drugs in Sport
- Permitted - No warnings
Adverse reactions
Gastrointestinal Disorders
- Constipation
- Diarrhoea
- Intestinal obstruction
- Flatulence
- Abdominal distension
- Bezoar
Immune, Blood and Lymphatic System Disorders
- Hypersensitivity
Interactions
Thickening agents
Monitoring
None routine. Specific cases may require
- Serum electrolytes
Prescribing points
Administration guidelines
- The sachet should not be opened until immediately before mixing as the powder is sterile
- Add 5 ml (1 teaspoon) of cooled, boiled water to the powder in a glass and mix to a smooth paste
- Add another 10 ml (2 teaspoons) of water to the paste and mix
- Mix immediately before use and shake well before administering the dose
Mechanism of action
Sodium alginate and magnesium alginate
Sodium alginate and magnesium alginate are salts of alginic acid. They combine with gastric acid to form a viscous gel, which acts as a physical barrier to the reflux of gastric contents.
Dosage forms
- Powder, oral
Formulation
COMBINATION PREPARATIONS
Sodium alginate/Magnesium alginate
Sachet (per 0.65g) 225mg/87.5mg
- Infant Gaviscon Aluminium Free (Reckitt) originator
References
1. https://www.medicines.org.uk/emc/medicine/21981 (16/09/2015_Forum_Gaviscon infant_pwd) 2. https://drive.google.com/drive/folders/1KvSB7Gbf7LLp7PxtQn0VI9E4FAFajdSD (30/09/2011_Reckitt_Gaviscon infant) 3. https://drive.google.com/drive/folders/1KvSB7Gbf7LLp7PxtQn0VI9E4FAFajdSD (08/06/2017_MDR_Gaviscon infant) 4. NAPOS The Drug Database for Acute Porphyria: A02BX13 Alginic acid; Accessed online 10 Jan 2019 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=A02BX13&l=gbr] 5. South African Institute for Drug-Free Sport; Gaviscon; Accessed online 11 Jan 2019 [http://www.drugfreesport.org.za/online-medication-check/]
Brands & products
1 product · cached snapshot- Infant Gaviscon Aluminium Free
POWPowder, oral· 1 product
from R254.83| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Infant Gaviscon Aluminium Freediscontinued | 225 mg/0.65g;mg/0.65g | 30 | Reckitt Benckiser Pharmaceuticals (Pty) Ltd | R254.83 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.